Abstract

This initiative is based on research that has been funded by the Consejeria de Educacion, Cultura y Deportes, JCCM, Spain, project ´ CCM17-PIC-036 (SBPLY/17/180501/000185)

Highlights

  • Ongoing research focuses on vaccines targeting SARS-CoV-2 for the prevention and control of COVID-19

  • Boosting the immune response to glycan α-Gal with a broader and not restricted to pathogen-specific immunity may contribute to the control of COVID-19 and to other pathogens that negatively affect the individual response to SARS-CoV-2

  • Despite the advances and potential impact that these vaccines represent for the prevention and control of COVID-19, interventions boosting the immune response with a broader and not pathogen-specific immunity may contribute to the control of COVID-19 and to potential reinfections by SARS-CoV-2-related genetic variants or other pathogens that negatively affect the individual response to SARS-CoV-2

Read more

Summary

Introduction

Ongoing research focuses on vaccines targeting SARS-CoV-2 for the prevention and control of COVID-19. Boosting the immune response to glycan α-Gal with a broader and not restricted to pathogen-specific immunity may contribute to the control of COVID-19 and to other pathogens that negatively affect the individual response to SARS-CoV-2.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call